Carmelo Nucera

5.8k total citations
38 papers, 1.4k citations indexed

About

Carmelo Nucera is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Carmelo Nucera has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Carmelo Nucera's work include Thyroid Cancer Diagnosis and Treatment (31 papers), Cancer-related Molecular Pathways (13 papers) and S100 Proteins and Annexins (9 papers). Carmelo Nucera is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (31 papers), Cancer-related Molecular Pathways (13 papers) and S100 Proteins and Annexins (9 papers). Carmelo Nucera collaborates with scholars based in United States, Italy and Australia. Carmelo Nucera's co-authors include Sareh Parangi, Jack Lawler, Richard A. Hodin, Matthew A. Nehs, Peter M. Sadow, Zeus A. Antonello, Michal Mekel, Neal Smith, Vânia Nosé and Alfredo Pontecorvi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Carmelo Nucera

38 papers receiving 1.4k citations

Peers

Countries citing papers authored by Carmelo Nucera

Since Specialization

Citations

This map shows the geographic impact of Carmelo Nucera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmelo Nucera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmelo Nucera more than expected).

Fields of papers citing papers by Carmelo Nucera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmelo Nucera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmelo Nucera. The network helps show where Carmelo Nucera may publish in the future.

Co-authorship network of co-authors of Carmelo Nucera

This figure shows the co-authorship network connecting the top 25 collaborators of Carmelo Nucera. A scholar is included among the top collaborators of Carmelo Nucera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmelo Nucera. Carmelo Nucera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancers 2024 ·Current Opinion in Endocrine and Metabolic Research ·Alessandro Prete, Carmelo Nucera	1
2	The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment 2023 ·Thyroid ·(unknown), Stephanie Li, Peter M. Sadow, Mohammadreza Abbasian, Ara Nazarian, Jack Lawler, Carmelo Nucera	8
3	Case Report of CCDC149–ALK Fusion: A Novel Genetic Alteration and a Clinically Relevant Target in Metastatic Papillary Thyroid Carcinoma 2022 ·Thyroid ·(unknown), (unknown), Lori J. Wirth, Carmelo Nucera, (unknown), Peter M. Sadow, Alain C. Mita, Wendy Sacks	8
4	Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights 2021 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Stephanie Li, Giovanni Roti, Michele R. Hacker, Andrew H. Fischer, Carmelo Nucera	13
5	Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network Analysis 2021 ·Molecules ·(unknown), Carmelo Nucera	5
6	Tumor Microenvironment–Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer 2021 ·Advances in experimental medicine and biology ·(unknown), Carmelo Nucera	12
7	Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAF ^V600E Papillary Thyroid Carcinoma 2020 ·Thyroid ·(unknown), (unknown), (unknown), Carmen Priolo, Zsuzsanna K. Zsengellér, Alfredo Pontecorvi, Isaac E. Stillman, Suzanne D. Burke, Xiaowen Liu, Carmelo Nucera	21
8	Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis 2018 ·Clinical Cancer Research ·Alessandro Prete, Agnes S. Lo, Peter M. Sadow, Swati S. Bhasin, Zeus A. Antonello, (unknown), Soumya Ullas, Jennifer N. Sims, John G. Clohessy, Ann M. Dvořàk, Tracey Sciuto, Manoj Bhasin, Joanne E. Murphy-Ullrich, Jack Lawler, S. Ananth Karumanchi, Carmelo Nucera	46
9	Expression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF 2015 ·Cancer Letters ·Amjad Husain, (unknown), Peter M. Sadow, Carmelo Nucera	12
10	Genomic and immunohistochemical analysis in human adrenal cortical neoplasia reveal beta-catenin mutations as potential prognostic biomarker 2015 ·PubMed Central ·Alexandra E. Kovach, Carmelo Nucera, Quynh Lam, (unknown), Dora Dias‐Santagata, Peter M. Sadow	5
11	Personalized Therapy in Patients With Anaplastic Thyroid Cancer: Targeting Genetic and Epigenetic Alterations 2014 ·The Journal of Clinical Endocrinology & Metabolism ·Neal Smith, Carmelo Nucera	58
12	Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAFV600E: New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment 2013 ·Frontiers in Endocrinology ·Mark Duquette, Peter M. Sadow, Jack Lawler, Carmelo Nucera	19
13	FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma 2012 ·Endocrine Related Cancer ·Roberto Bellelli, Maria Domenica Castellone, Ginesa García‐Rostán, Clara Ugolini, Carmelo Nucera, Peter M. Sadow, Tito Claudio Nappi, Paolo Salerno, (unknown), Fulvio Basolo, (unknown), Giuliana Salvatore, Massimo Santoro	35
14	Late Intervention with anti-BRAFV600E Therapy Induces Tumor Regression in an Orthotopic Mouse Model of Human Anaplastic Thyroid Cancer 2011 ·Endocrinology ·Matthew A. Nehs, Carmelo Nucera, (unknown), Peter M. Sadow, Dieter Morales-García, Richard A. Hodin, Sareh Parangi	46
15	B-Raf ^V600E and thrombospondin-1 promote thyroid cancer progression 2010 ·Proceedings of the National Academy of Sciences ·Carmelo Nucera, Alessandro Porrello, Zeus A. Antonello, Michal Mekel, Matthew A. Nehs, Thomas J. Giordano, Damien Gerald, Laura E. Benjamin, Carmen Priolo, Efisio Puxeddu, Stephen P. Finn, Barbara Jarząb, Richard A. Hodin, Alfredo Pontecorvi, Vânia Nosé, Jack Lawler, Sareh Parangi	149
16	Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer 2010 ·Surgery ·Matthew A. Nehs, (unknown), Carmelo Nucera, Richard A. Hodin, Sareh Parangi	28
17	FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma 2009 ·Clinical Cancer Research ·Carmelo Nucera, Jérôme Eeckhoute, Stephen P. Finn, Jason S. Carroll, Azra H. Ligon, Carmen Priolo, Guido Fadda, Mary Toner, Orla Sheils, Marco Attard, Alfredo Pontecorvi, Vânia Nosé, Massimo Loda, Myles Brown	67
18	Maternal thyroid hormones are transcriptionally active during embryo–foetal development: results from a novel transgenic mouse model 2009 ·Journal of Cellular and Molecular Medicine ·Carmelo Nucera, (unknown), Cecilia Tiveron, Antonella Farsetti, Federico La Regina, (unknown), Shou‐Ching Shih, Fabiola Moretti, (unknown), Francesca Mancini, Ada Sacchi, Francesco Trimarchi, Alessandro Vercelli, Alfredo Pontecorvi	21
19	Role of B-RafV600E in differentiated thyroid cancer and preclinical validation of compounds against B-RafV600E 2009 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Carmelo Nucera, Melanie Goldfarb, Richard A. Hodin, Sareh Parangi	41
20	BRAF(V600E) mutation and the biology of papillary thyroid cancer 2008 ·Endocrine Related Cancer ·Francesco Frasca, Carmelo Nucera, Gabriella Pellegriti, (unknown), Marco Attard, Marco Stella, Massimo Loda, Veronica Vella, Carla Giordano, Francesco Trimarchi, Emanuela Mazzon, Antonino Belfiore, Riccardo Vigneri	205

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact